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Abstract
Background: Trypanosoma brucei, the causative agent of African sleeping sickness, undergoes a
complex developmental cycle that takes place in mammalian and insect hosts and is accompanied
by changes in metabolism and cellular morphology. While differences in mRNA expression have
been described for many genes, genome-wide expression analyses have been largely lacking.
Trypanosomatids represent a unique case in eukaryotes in that they transcribe protein-coding
genes as large polycistronic units, and rarely regulate gene expression at the level of transcription
initiation.
Results: Here we present a comprehensive analysis of mRNA expression in several stages of
parasite development. Utilizing microarrays that have multiple copies of multiple probes for each
gene, we were able to demonstrate with a high degree of statistical confidence that approximately
one-fourth of genes show differences in mRNA expression levels in the stages examined. These
include complex patterns of gene expression within gene families, including the large family of
variant surface glycoproteins (VSGs) and their relatives, where we have identified a number of
constitutively expressed family members. Furthermore, we were able to assess the relative
abundance of all transcripts in each stage, identifying the genes that are either weakly or highly
expressed. Very few genes show no evidence of expression.
Conclusion: Despite the lack of gene regulation at the level of transcription initiation, our results
reveal extensive regulation of mRNA abundance associated with different life cycle and growth
stages. In addition, analysis of variant surface glycoprotein gene expression reveals a more complex
picture than previously thought. These data provide a valuable resource to the community of
researchers studying this lethal agent.
Background
Trypanosoma brucei subspecies are unicellular pathogens
that infect humans, as well as domestic and wild animals.
The infections of humans are fatal without treatment, and
the treatments are suboptimal due to resistance, toxicity,
and cost. Furthermore, no vaccine is available due to ram-
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pant antigenic variation in which hundreds of variant sur-
face glycoproteins (VSGs) are sequentially displayed on
the parasite surface [1]. Additionally, this group of organ-
isms, along with their relatives Trypanosoma congolense and
Trypanosoma vivax, have hampered the development of
sub-Saharan Africa by their severe effects on cattle and
draft animals.
In both the mammalian host and the insect vector (tsetse
fly), T. brucei undergoes multiple developmental changes
that are reflected by changes in morphology, surface pro-
teins, cell division, and metabolism, although all stages
are extracellular and motile, courtesy of a single flagellum.
When first injected into the mammalian host by the bite
of a tsetse fly, the stationary metacyclic phase parasites re-
enter the cell cycle as rapidly dividing slender blood-
stream forms (BF). This stage relies on glycolysis for the
generation of ATP, and has a single tubular mitochon-
drion. After several days, short stumpy forms appear.
These forms are arrested in G0/G1 and still express VSG,
but show modest metabolic changes that appear to pres-
age the next stage of parasite development [2-4]. When
taken up by the fly, they readily transform into procyclic
forms (PF) that multiply in the insect midgut. This stage
of the parasite expresses a different surface coat, made up
of a small family of proteins termed procyclins [5]. Glyc-
olysis is down-regulated, amino acid metabolism is
induced, and the mitochondrion enlarges and more elab-
orate cristae develop. After one to two weeks, the PFs jour-
ney to the salivary glands where they transform into
epimastigotes and then into mammalian-infective meta-
cyclic forms [6]. While T. brucei slender BFs and PFs are
routinely cultured in vitro, epimastigotes and metacyclic
forms are not readily available.
In contrast to most other organisms, trypanosomatids do
not regulate gene expression at the transcriptional level,
except for the major surface antigens of African trypano-
somes such as T. brucei [7]. Almost all genes are tran-
scribed as large polycistronic clusters, but adjacent genes
may show widely differing levels of mRNA, and these lev-
els may vary during the parasite life cycle. This develop-
mental regulation of mRNA abundance is largely attained
via  changes in decay rate, predominantly attributed to
sequences within the 3' untranslated region (UTR) [8].
Early studies of changes in gene expression between slen-
der BF and PF suggested that only about 2% of probes
showed significant changes in signal between stages
[9,10]. However, these initial studies relied on arrays that
utilized relatively large anonymous fragments of the
genome as probes (~2.25 kb), and used a cutoff of 2.5-
fold change between minimum and maximum signal. The
elucidation of the complete genome of T. brucei strain 927
in 2005 [11] affords the opportunity to examine global
changes in mRNA expression using a gene-specific
approach. A recent study examined a subset of about 550
genes for their expression in BF as compared to PF para-
sites [12]. The genes were selected on the basis of their
potential for regulation, based on analysis of the litera-
ture, and many were found to be stage-regulated. More
recently, microarrays have been used to search for changes
in gene expression following knockdown or knockout of
genes encoding RNA binding proteins [13,14].
Until now, the microarray studies performed on T. brucei
have been either sub-genomic or have utilized a single
probe for each gene. In this study, we have used Nimble-
gen microarrays that employed eight probes per gene to
assess gene expression in T. brucei 927, examining the
stages which are readily obtained in the laboratory. Those
stages included in vitro cultured slender BF (cBF), as well
as slender and stumpy BF harvested from infected rats. We
also studied both log and stationary phase PFs (PF-log,
PF-stat). Our results revealed that mRNA expression in
cBF was little different from that seen in the slender BFs
harvested from rats. A modest number (~100) of changes
were seen in stumpy BF. As expected, many changes were
observed when cBF and PF-log parasites were compared,
with several hundred genes showing at least a 2-fold
change in mRNA abundance. Surprisingly, comparison of
PF-log and PF-stat parasites showed an even larger
number of changes. The arrays not only allowed us to
compare differences between stages, but also to examine
expression levels of various genes within a sample. About
half of genes ranked in the top 10% of signals in cBF were
also expressed to high levels in all other stages. A signifi-
cant fraction of these highly expressed genes encoded
hypothetical proteins. Very few genes showed no evidence
of expression.
Results and Discussion
This study reports our findings on changes in gene expres-
sion between those stages of T. brucei that can be readily
studied in the laboratory. During natural infections in the
vertebrate host, T. brucei progresses from the actively
dividing slender BF to the non-dividing stumpy BF. This
form is primed for differentiation to procyclic forms in the
insect host. We examined the expression level of nearly all
predicted protein-coding genes of strain 927 T. brucei, as
well as many RNA genes, in five different parasite popula-
tions. Most of the analyses reported here are restricted to
nuclearly encoded transcripts, although some findings for
mitochondrially derived transcripts are noted. Three bio-
logical replicates were used for each test condition. Three
of the five sets were derived from in vitro culture under
highly standardized conditions: log-phase cultured
bloodstream forms (cBF), log-phase cultured procyclic
forms (PF-log), and stationary-phase procyclic forms (PF-
stat) (see Additional file 1). The remaining two samples,
slender BF and stumpy BF, were derived from infected ratsBMC Genomics 2009, 10:482 http://www.biomedcentral.com/1471-2164/10/482
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and were likely to show more inter-sample variability,
since they were grown for varying times in rats, and the
animals became progressively less healthy after irradia-
tion and infection. Since the stumpy BF populations were
the last to be harvested and each contained a variable pro-
portion of intermediately differentiated forms, these pop-
ulations were the most biologically variable. They ranged
from 76% to 93% morphologically stumpy and 68% to
88% of cells expressed the PF marker EP procyclin upon
appropriate stimulation (see Table 1). The slender BF
populations showed less than 5% intermediate or stumpy
forms and less than 1% expressed procyclin after stimula-
tion.
The Nimblegen arrays that were hybridized with cDNA
prepared from each parasite population contained multi-
ple probes per gene (in most cases, eight), and three cop-
ies of these probe-sets per chip. After normalization to
allow for cross-chip comparisons, we calculated a single
value for each set of triplicate probes using Tukey's
biweight formula. We then obtained a single gene level
value using the Tukey biweight of the signals for the
probes corresponding to each gene (Additional file 2). In
most cases, this value represented the "average" of 72 data
points collected for every protein-coding gene (45 for
RNA genes) in each of the five growth conditions. Thus, as
detailed in Methods, we were able to utilize robust statis-
tical analyses that increase our confidence in the findings
of the comparisons reported below.
Gene expression levels
The normalized expression values from the 8110 probe-
sets corresponding to nuclear genes were hierarchically
clustered using the TMeV software package and are shown
graphically as a heat map in Figure 1A. A small number of
genes (those colored black or dark blue in the middle of
the figure) showed no or very low expression under any
condition, and a similar number (colored red) showed
high expression levels in some (top) or all (bottom) con-
ditions. However, the large majority of the genes showed
low (blue) or moderate (green or yellow) expression lev-
els. Each biological sample set showed a similar distribu-
tion of signal intensities obtained for the 8004 probe-sets
corresponding to nuclear protein-coding genes, with the
curves obtained from cBF and PF-stat (the most divergent
samples) shown Figure 1B. This figure also depicts the sig-
nals obtained for the 345 probe-sets that map to multi-
copy CDSs. This curve was skewed dramatically to the
right, as compared to the total sample of probe-sets, con-
firming gene amplification as a clear strategy for increas-
ing gene expression in T. brucei. Indeed, 20 of the 50
probe-sets detecting the highest signals map to two or
more genes (see below and Table 2). However, the signals
did not follow in rank order of number of genes detected
by the probe-sets.
For the total probe-sets, there is a large peak centered at
~4600 for the PF-stat and ~5800 for cBF. In both cases, the
peak moves sharply down towards lower values, with a
small shoulder at ~200. When the same arrays were
probed with RNA derived from a different strain, this
shoulder was more pronounced, and a corresponding
increase in probe-sets with signal intensities less than 200
was observed (unpublished data). Since many of these
probe-sets mapped to VSGs, most of which are not con-
served between strains, a signal level of ~200 can be taken
as a generous estimate of background for non-transcribed
regions. However, almost all regions of the T. brucei
genome are thought to be constitutively transcribed, and
hence even those genes whose mRNAs are unstable would
likely show a signal higher than this background. The
number of probe-sets that failed to show a signal level of
less than four times the "non-transcribed background"
signal (i.e., 800) in least one of the five different biological
conditions was small (164 protein-coding genes). Even
then, VSG genes, which are subject to clonal variations in
expression, accounted for all but 65 of this set. The major-
ity (55) of the remaining genes have unknown function,
with most of these (44) found only in T. brucei, raising the
possibility that they do not represent authentic genes. In
addition, almost all of these low-expressing genes are
located in sub-telomeric clusters of VSGs or expression
site associated genes (ESAGs) or are immediately adjacent
to convergent strand-switch regions where transcription
terminates [15,16]. Even when considering only cBF par-
asites, only 133 predicted non-VSG protein-coding genes
Table 1: Characterization of bloodstream form T. brucei from animals
Cell type Parasitemia Cell morphology procyclin staining
(cells/ml) Slender Intermediate Stumpy positive negative
Slender 5.6 × 107 97% 3% 0% 0% 100%
1.2 × 108 97.6% 2.4% 0% 0% 100%
9.4 × 107 94.5% 5.5% 0% 1.0% 99.0%
Stumpy 5.2 × 108 0% 20.7% 79.3% 88.2% 11.8%
6.1 × 108 0.6% 6.4% 93% 89% 11%
6.9 × 108 5.1% 18.5% 76.4% 67.5% 32.5%BMC Genomics 2009, 10:482 http://www.biomedcentral.com/1471-2164/10/482
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Table 2: The 50 most highly expressed protein-coding genes
Rank name Gene #a Description Max Max_stageb
1 Tb927.1.4620 1 hypothetical conserved 64153 cBF
2 Tb927.8.7410 1 calreticulin 56648 slender BF
3 Tb927.1.2380 4 alpha tubulin 55277 slender BF
4 Tb10.6k15.0020 1 EP1 procyclin 53583 PF-stat
5 Tb927.6.510 1 GPEET2 procyclin precursor 52410 PF-log*
6 Tb927.4.5010 1 calreticulin 51616 cBF*
7 Tb927.1.2350 4 beta tubulin 50396 PF-log
8 Tb10.70.1370 1 fructose-bisphosphate aldolase glycosomal 50161 slender BF*
9 Tb10.406.0390 11 histone H2B 49321 slender BF
10 Tb927.5.2260 1 hypothetical conserved 49312 PF-log*
11 Tb927.1.2560 7 hypothetical 49217 PF-log
12 Tb11.02.4690 1 Hypothetical 48922 cBF
13 Tb10.6k15.2040 1 glucose transporter 1B 48339 slender BF*
14 Tb11.1190 1 hypothetical 48183 cBF
15 Tb927.1.4600 5 F-box motif protein, CFB1A-1E 47725 cBF*
16 Tb927.8.4710 3 amino acid transporter 47553 slender BF
17 Tb927.8.4700 2 amino acid transporter 47452 stumpy BF
18 Tb927.1.2530 7 histone H3 47213 slender BF
19 Tb927.4.4730 1 amino acid transporter 46274 PF-stat*
20 Tb11.01.3110 1 heat shock protein 70 45565 PF-log
21 Tb11.01.7800 1 nucleoside diphosphate kinase 45393 PF-log
22 Tb927.5.1810 1 p67 lysosomal membrane glycoprotein 44412 stumpy BF
23 Tb927.7.6040 2 Hypothetical 44288 slender BF
24 Tb927.8.5260 1 60S ribosomal protein L39 44187 PF-stat
25 Tb10.406.0360 2 histone H2B 44099 slender BF*
26 Tb11.01.0355 1 ribosomal protein S26 43926 PF-stat
27 Tb927.7.2930 13 histone H2A 43798 slender BF
28 Tb09.160.5400 1 ESAG9 43669 stumpy BF*
29 Tb10.70.5650 3 elongation factor 1-alpha TEF1 43424 cBF
30 Tb09.244.2740 2 60S ribosomal protein L5 42964 PF-log
31 Tb927.8.8300 1 amino acid transporter 42640 PF-stat*
32 Tb10.70.3370 2 40S ribosomal protein S3a 42603 stumpy BF
33 Tb10.26.1080 1 heat shock protein 83 42429 PF-log
34 Tb927.1.580 1 phosphate-repressible phosphate permease 42138 PF-stat
35 Tb927.6.970 9 cysteine peptidase precursor 41870 slender BF
36 Tb927.5.810 1 hypothetical conserved, zinc finger protein 41840 stumpy BF
37 Tb10.6k15.0030 1 EP2 procyclin 41304 PF-stat*
38 Tb10.6k15.2020 1 glucose transporter 2A 40774 PF-stat
39 Tb10.v4.0052 1 microtubule-associated protein 2 40337 cBF
40 Tb09.211.0340 2 60S ribosomal protein L10 40302 PF-stat
41 Tb10.70.2650 2 elongation factor 2 39867 PF-log*
42 Tb927.4.1860 1 ribosomal protein S19 39840 PF-stat
43 Tb927.8.5460 3 flagellar calcium-binding protein 44 kDa 39840 cBF
44 Tb927.4.1800 2 ribosomal protein L3 mitochondrial 39831 PF-stat
45 Tb927.8.6180 1 60S ribosomal protein L26 39793 stumpy BF
46 Tb927.8.6450 1 inhibitor of cysteine peptidase chagasin 39785 stumpy BF*
47 Tb11.01.3180 2 guanine nucleotide-binding protein beta subunit-like 39559 PF-log
48 Tb927.5.1710 1 ribonucleoprotein p18, complex V 39457 PF-log
49 Tb10.406.0340 1 histone H2B 39390 cBF
50 Tb927.1.2310 1 Hypothetical 39078 PF-stat*
anumber of genes detected by probe set
bAsterisk indicates gene is regulated at least two-fold between highest and lowest sample sets.BMC Genomics 2009, 10:482 http://www.biomedcentral.com/1471-2164/10/482
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had a signal <800, and of these only 22 had annotated
function. Notably, most of these genes were expressed to
higher levels in at least one other stage, and those that
were low in all stages were located in a sub-telomeric or
convergent strand-switch region context.
The protein-coding genes were ranked according to their
maximal expression level in any stage, and broadly cate-
gorized according to their annotated function (Figure 1C).
As suggested above, VSG genes and T. brucei-specific genes
of unknown function accounted for most of the genes
showing the lowest expression (86% of the bottom 2%
and 64% of the bottom 5%). Conversely, genes which are
more highly expressed tend to have some type of func-
tional annotation; indeed many of these have been stud-
ied experimentally.
We identified the nuclear CDSs with the top 10% of sig-
nals for each biological condition. The genes were individ-
ually examined and placed into categories based on their
Distribution of different expression levels for all T. brucei nuclear genes Figure 1
Distribution of different expression levels for all T. brucei nuclear genes. A. Heatmap showing the signals obtained 
for cBF, slender BF (SL-BF), stumpy BF (ST-BF), PF-log), and PF-stat. B. Density plot of gene level intensities for nuclear pro-
tein-coding genes. Blue line, PF-stat; red line, cBF; dashed red line, cBF signals from the multicopy probe-sets. The points mark 
the signals in cBF corresponding to the percentile rank indicated. C. Distribution of protein-coding gene categories varies 
according to expression level. The maximal expression level (Tukey mean) for each gene was ranked. Genes encoding proteins 
with an ascribed function or location are included in the functional category, the remaining genes were divided into those spe-
cific to T. brucei (unknown Tb) and those conserved in at least one other species (unknown cons).BMC Genomics 2009, 10:482 http://www.biomedcentral.com/1471-2164/10/482
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annotation and/or their proteomic detection in specific
sub-cellular fractions. Figure 2A shows the distribution of
these genes into broad categories as in Figure 1C, while
Figure 2B shows the distribution of genes with ascribed
function (yellow in Figure 2A) according to various cate-
gories of biological function or location for the each of the
five different biological conditions. As indicated in Figure
1C, above, genes with unknown function were under-rep-
resented in the highly expressed category, as compared to
the whole genome, and this was most striking in the PF-
log cells (Figure 2A). Overall, the categories with the larg-
est numbers of highly expressed genes were translation,
metabolism, or cytoskeleton, with the majority (99 out of
144) of the genes in the translation category encoding
cytoplasmic ribosomal proteins. Genes involved in mito-
chondrial function were highly represented in the top
expressors in the PF stages, but more modestly repre-
sented in BF stages. As expected, significantly higher pro-
portions of ESAGs or genes related to them (GRESAGs)
were expressed at high levels in all BF stages than in the PF
stages. In general, relatively similar proportion of genes
were found in each category in all biological stages,
although the number of genes involved in metabolism
was increased in PF-log and genes encoding cytoskeleton
proteins decreased in stumpy BF. However, this does not
mean that the same genes are expressed to high levels in
all stages. For example, 13% of mRNAs highly expressed
in cBF were more than 2-fold up-regulated as compared to
PF and similarly 12% of mRNAs highly expressed in PF
were more than 2-fold up-regulated as compared to cBF
(see below).
Among the 800 most highly expressed nuclear CDSs in
cBF, 307 were highly expressed in every condition exam-
ined. Surprisingly, 111 of these had unknown function.
Thus, there is a large set of highly expressed T. brucei-spe-
cific (20) or conserved (91) genes that have not been
ascribed a function; including nine of the 50 most highly
expressed genes in cBF (see Table 2). Some of the "hypo-
thetical" proteins encoded by these nine genes have been
shown to exist by proteomic analyses (Tb11.01.2800,
Tb10.6k15.1500) or other studies (Tb927.1.4600 [13]).
Conversely, two other "hypothetical genes" lie in inter-
genic regions between coding regions that are highly
expressed, raising the possibility that these are not sepa-
rate genes, but rather simply sequences within 3' UTRs of
Distribution of functional gene category in the top 10th percentile of expression values in each biological condition Figure 2
Distribution of functional gene category in the top 10th percentile of expression values in each biological condi-
tion. A. Distribution of the functional gene categories as described in Figure 1C. B. Further breakdown of functional category. 
Only those categories with at least ten genes at one condition are shown. The functional (blue bar) and location (red bar) cat-
egories are indicated below the X-axis.
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the neighboring genes. The first, as represented by
Tb927.1.2540, is one of a set of seven almost identical
putative genes (six of which are annotated as "hypotheti-
cal protein, unlikely") that are interspersed between the
histone H3 genes. The second, as represented by
Tb927.1.4590, corresponds to a set of genes that are inter-
spersed between the highly expressed CFB1  genes.
Tb11.1190 encodes a putative protein which is composed
of 49 repeats of 68 amino acids and is represented on the
microarray by a single probe corresponding to a unique
sequence at the C-terminus. Tb11.02.4690 specifies a 22
kDa protein with a signal sequence and three transmem-
brane domains. It is expressed to a much higher level than
the flanking genes, indicating it is a distinct mRNA. The
last of these nine genes, Tb927.4.1000, encodes a 25 kDa
protein that is also expressed much more highly than the
adjacent genes.
Differential gene expression
Comparison of the Tukey mean maximum and minimum
signal levels for all probe-sets corresponding to nuclear
genes revealed 122 genes that showed a greater than 10-
fold change between two or more of the five biological
conditions tested. Of these, 30 were VSG,  VSG-related
(VR) genes, or ESAG/GRESAGs, many of which are associ-
ated with antigenic variation. A total of 446 genes (includ-
ing 161 VSGs and ESAGs) showed more than 4-fold
variation, while at the 2-fold level, 2105 genes (including
233 VSGs and ESAGs) showed a statistically supported
difference in expression. Thus, over one-fourth of all of
the genes assessed on the microarray were differentially
expressed (i.e. q-value of <5% in multi-class significance
analysis of microarrays (SAM)) between at least two con-
ditions. This dataset was further reduced to those showing
a >2-fold deviation from the mean of all five conditions in
at least one sample, and by excluding all genes encoding
VSG/VRs and ESAG/GRESAGs (which were analyzed sep-
arately, see below). These 534 probe-sets were K-median
clustered using settings indicated in the Methods to yield
nine clusters which contained between 31 and 80 genes
(Figure 3 and Additional file 3). Each of these clusters rep-
resents a distinct pattern of gene expression, although
some are similar. Overall, these highly regulated genes are
enriched in those involved in metabolism, proteolysis,
translation and T. brucei-specific unknown functions, but
under-represented in those genes that are conserved but
have unknown function. However, individual clusters
show differential enrichment in particular functional gene
categories.
Figure 3A shows the heatmap depicting gene clustering,
while Figure 3B shows overlaid expression patterns graph-
ically for every gene in each cluster. Figure 3C depicts spe-
cific examples that illustrate the expression patterns
characteristic of the gene clusters. Genes in clusters 5, 6, 7
and 8 all have higher mRNA levels in BF than in PF,
although the clusters each show subtle differences in
expression pattern. For example, cluster 8 contains genes
that encode mRNAs substantially down-regulated in PF-
log and PF-stat, whereas in cluster 6 the down-regulation
in PF is more modest and some genes begin to decrease
expression in stumpy BF. Cluster 8 is enriched in genes
involved in metabolism and adenosine transport and also
includes several genes encoding 64-65 kDa invariant sur-
face glycoproteins (ISGs) and procyclin-associated genes
(PAGs). Cluster 6 contains genes encoding three 75 kDa
ISGs, several proteases, and a substantial number of T.
brucei-specific proteins of unknown function. Cluster 7
contains genes that are somewhat down-regulated in PF-
log (relative to BF), but are expressed at even lower levels
in PF-stat. Genes encoding proteins involved in interac-
tion, metabolism, protein folding and protein transport
or modification, are overrepresented in this cluster. Con-
versely, cluster 5 contains 60 genes that are down-regu-
lated to a greater extent in PF-log than in PF-stat. This
cluster is dominated by genes encoding proteases and T.
brucei-specific proteins with unknown function. The
former category includes several paralogues encoding
homologues of the Leishmania gp63 surface protease.
Clusters 2, 3, and 4 show different patterns of up-regula-
tion with respect to the two PF biological conditions.
Cluster 2 contains genes that are up-regulated in PF-log,
but not in PF-stat. For some genes this change in expres-
sion begins in stumpy BFs. The genes in this cluster are
over-represented for those encoding proteins involved in
interaction, metabolism, RNA processing, transcription,
translation and cytoskeleton function. Their reduced
expression in PF-stat is consistent with cessation of growth
functions upon entry into stationary phase. Indeed we
observed a significant accumulation of rRNA precursors in
the PF-stat samples upon analysis on the Agilent BioAna-
lyzer (not shown). Conversely, cluster 3 contains genes
that are up-regulated only in PF-stat and mostly have
unknown function, including eight that are T. brucei-spe-
cific. It is possible that some of these gene products are
involved in preparation for differentiation into epimastig-
otes, the next stage in the parasite life cycle. Finally, cluster
4 contains genes with higher expression levels in both PF-
log and PF-stat and is enriched in genes encoding proteins
involved in metabolism, proteolysis, or with unknown
function but located on the cell surface or mitochondrion.
As discussed in more detail below, this is consistent with
the switch to mitochondrial pathways for energy genera-
tion in procyclics.
Cluster 1 contains the largest number of genes, with 82
members. The expression of these genes is lower in PF-stat
(and stumpy BF in some cases), but the genes are
expressed at higher levels in cBF and slender BF than seenBMC Genomics 2009, 10:482 http://www.biomedcentral.com/1471-2164/10/482
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in cluster 2. These genes are over-represented in those
involved in metabolism, DNA replication/repair, protein
folding, proteolysis and translation, consistent with their
down-regulation in stationary-phase cells. Cluster 9, with
31 members, is the smallest cluster. The pattern of gene
regulation is similar to cluster 1, but with some up-regula-
tion in PF-log. Like cluster 1, this cluster is enriched in
genes involved in DNA replication/repair.
The existence of these varied expression patterns implies a
complex set of regulatory mechanisms operating at the
RNA level to control the abundance of transcripts
encoded by nuclear genes. The specific proteins involved
in these processes are only beginning to be examined (see
for example refs. [13,14,17]).
In contrast to the analyses above that examined the tran-
scripts showing the most variation in abundance, we also
looked at the transcripts that showed the least variation.
Genes such as these would provide excellent controls for
studies of developmental changes in gene expression. We
identified 830 genes with a maximum variation in expres-
sion between the five stages of <25% (see Additional file
2). As expected, genes encoding proteins involved in
Cluster analysis of highly-regulated mRNAs Figure 3
Cluster analysis of highly-regulated mRNAs. The 534 genes showing two-fold deviation from the mean expression value 
in at least one of the 5 samples using multi-class SAM analysis were analyzed. ESAGs, GRESAGs, VSGs, and VRs were excluded 
from the analysis. A. Heatmap. The genes were subjected to K-median clustering of the log2 ratios into 9 clusters, as num-
bered. B. Signals corresponding to individual probe-sets within each cluster. For each probe-set, the signal for each biological 
condition was compared to the mean of those signals across conditions (log2 ratio). The biological conditions from left to right 
are: cBF, slender BF, stumpy BF, PF-log and PF-stat. C. Tukey mean expression values across biological conditions for a single 
gene from each cluster, as numbered. The individual genes are: 1, Tb11.42.0003, t protein complex  subunit; 2, Tb10.61.1990, 
ribosome biogenesis protein; 3, Tb927.3.3990, RNA editing protein B6; 4, Tb09.160.1820, cytochrome oxidase subunit V; 5, 
Tb11.02.5610, GP63-1 surface protease; 6, Tb927.5.390, ISG75 invariant surface glycoprotein; 7, Tb10.70.3560, predicted 
RING finger protein; 8, Tb927.2.6240, adenosine transporter 2; 9, Tb927.7.6370, conserved hypothetical protein.
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known stage-regulated processes such as glycolysis and
electron transport are significantly under-represented.
However, the group is slightly enriched for genes of
unknown function. Genes encoding proteins involved in
lipid or fatty acid metabolism are also over-represented,
comprising 28% of the metabolic enzymes that showed
little variation as opposed to 11% of all metabolic
enzymes. Similarly, genes encoding proteins of the ubiq-
uitin pathway represent 40% of all protease-related genes,
but 85% of the subset of protease-related genes that
showed little variation. Genes involved in histone acetyla-
tion or chromatin structure, such as Tb927.7.1690 and
Tb927.4.2520 (which encode transcriptional silencer
Sir2) also tended to maintain similar mRNA levels
between life cycle stages.
Comparison of cBF and log phase PF forms
In order to identify differences in gene expression between
specific conditions, we conducted pair-wise comparisons
of specific datasets (including cBF versus slender BF, slen-
der BF versus stumpy BF, cBF versus PF-log, and PF-log ver-
sus PF-stat) using SAM, setting the q-value to <5% and the
fold-change to >2 (see Methods). Because VSG expression
is both clonal and highly variable, VSGs are excluded from
the gene tallies below, unless otherwise noted.
Comparing the signals between cBF and PF-log, 691 genes
were found to be differentially expressed. When the strin-
gency of the SAM analysis was reduced to a 1.7-fold
change, 963 genes were detected. A further reduction to
1.5-fold identified 1508 genes--approximately 19% of the
genome. Thus, a relatively large fraction of the genome
encodes mRNAs that differ in abundance between these
two stages. Figure 4A shows a comparison of the func-
tional categories of the genes showing >2-fold regulation;
these are individually listed (along with their fold-changes
in mRNA expression and q-values) in Additional file 4.
Table 3 itemizes those genes upregulated in cBF that have
predicted functions (excluding VSGs and ESAGS, which
are discussed below).
As can be seen in Figure 4A, categories of genes where cBF
show higher expression than PF-log cells include ESAGs
and GRESAGs, uncharacterized proteins bearing interac-
tion motifs (such as zinc fingers and leucine-rich repeats),
and known surface and secreted proteins (in part because
there are multiple distinct genes in several surface protein
families). However, it is also interesting that a larger
number of genes upregulated in cBF encode proteins with
hypothetical status (conserved or T. brucei-specific) that
have signal sequences. This fits well with the finding that
the secretory and endocytic systems are more active in BF
than PF [18]. However, unlike Koumandou et al. [12], we
did not find that mRNAs specifying proteins involved in
secretory traffic were highly up-regulated in BF.
Categories with more representatives up-regulated in PF-
log cells include those encoding mitochondrial proteins,
metabolic proteins, and translation. It is known that the
metabolism of PF (which can use both glucose and amino
acids for energy metabolism) is more complex than BF
(which are highly glycolytic) [19], presumably accounting
for the more diverse set of metabolic genes up-regulated
in PF-log cells. In PF, the mitochondrion becomes
enlarged with more fully developed cristae and the respi-
ratory chain is active [2]. These changes are reflected in the
increased expression of a large number of genes (72)
encoding products associated with the mitochondrion,
including 27 that are of unknown function. In contrast, a
single gene known to encode a mitochondrial protein is
upregulated in cBF: the alternative oxidase. This oxidase is
required for the glycerophosphate shuttle that allows gly-
colysis to continue [20].
The comparison of mRNA abundance between these two
stages led to the identification of several groups of inter-
esting genes. These include those encoding nucleoside
transporters NT2-NT7 which reside in an array immedi-
ately adjacent to the sub-telomeric VSG  cluster at the
"right" end of chromosome 2. There they alternate with a
set of iron-ascorbate oxidoreductase genes (see
Tb927.2.6180, Tb927.2.6230, Tb927.2.6310) that have
not been functionally characterized to our knowledge.
The NT genes were reported to be more highly expressed
in BF than PF forms, a finding which we also observe [21].
Interestingly, all of these oxidoreductase genes are also
significantly more highly expressed in cBF than PF-log
(3.3-13.2-fold, see Table 3). Three additional iron/ascor-
bate oxidoreductase genes are found on chromosomes 5,
7, and 9 -- these are each expressed to similar levels in cBF
and PF-log. Thus, the chromosome 2 region represents a
rare cluster of genes encoding similarly regulated mRNAs.
Another interesting case is that of VSP1, an acidocalciso-
mal pyrophosphatase encoded by two tandemly linked
genes (Tb11.02.4910 and Tb11.02.4930) with almost
identical coding regions [22]. The array data show that the
two genes are reciprocally regulated, which may poten-
tially be traced to their divergent 3' UTRs.
Comparison of gene expression in BF under different 
conditions
We compared the expression of all nuclear genes in slen-
der BF isolated from infected animals with the expression
in slender BF obtained by in vitro culture (cBF) and the
expression in stumpy BF from animals. In comparison of
cBF and slender BF, other than a few VSG genes, no gene
showed a difference in expression that met our criteria of
a 2-fold change and q-value < 5%. Additional file 5 lists
those genes that showed more moderate (>1.5-fold) or
less well-supported changes (q-value < 15). However, two
ISG64 genes (Tb927.5.1390 and Tb927.5.1430) showed aBMC Genomics 2009, 10:482 http://www.biomedcentral.com/1471-2164/10/482
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Table 3: Genes with functional annotation that are up-regulated in cBF as compared to PF-loga
Description SysID (fold changeb, signal in cBF)
Nucleic acid
cold shock DNA binding domain protein Tb927.4.4520 (3.8, 11127), Tb927.8.7820(3.1, 30733)
DNA binding motif protein Tb927.8.8270 (2.1, 5130)
methylated DNA binding motif protein Tb09.160.1490 (2.1, 6911)
SNF2 DNA repair protein Tb927.7.4650 (3.6, 9704)
DNA topoisomerase II Tb11.01.3390 (2.2, 20052)
heterogeneous nuclear ribonucleoprotein H/F Tb927.2.3880 (2.5, 19993)
RNA-binding protein Tb927.6.3480 (4.6, 15068), Tb927.7.3730 (2.4, 19060), Tb927.8.2780 (4.1, 22483, 
Tb10.389.1640 (2.9, 4885), Tb11.01.3940 (2.9, 6039)
Interaction Motifs
hypothetical conserved, ankyrin repeat Tb11.01.6010 (2.1, 9639), Tb927.7.1420 (2.2, 13373)
hypothetical conserved, FHA and BRCT domains Tb927.4.500 (2.6, 10222)
hypothetical conserved, PX domain Tb927.7.4500 (2.3, 19542)
hypothetical conserved, RING finger Tb10.70.3560 (2.4, 6310)
hypothetical conserved, zinc finger Tb10.389.0740 (7.6, 16571), Tb10.70.2020 (4.7, 8391), Tb11.01.0220 (2.7, 20691), 
Tb10.70.1850 (2.7, 3725), Tb09.211.1720 (2.5, 18066), Tb927.3.5390 (2.3, 3358), Tb11.01.0090 
(2.1, 19108), Tb11.02.2470 (2.0, 15163), Tb11.01.8270 (2.3,18420)
leucine-rich repeat protein Tb11.02.1564 (5.1, 5086), Tb927.3.1490 (4.8, 3199), Tb927.3.580 (3.2, 7044), Tb11.02.1580 
(2.2, 15932)
zinc-binding protein (Yippee) Tb927.6.4810 (1.9, 3902)
Metabolism
acidic phosphatase Tb927.5.610 (3.9, 21844)
acidocalcisomal pyrophosphatase VSP1 Tb11.02.4930 (2, 21100)
alternative oxidase Tb10.6k15.3640 (5.2, 25749)
arginine kinase Tb09.160.4570+1 (2.1, 8792)
aspartate aminotransferase Tb10.70.3710 (2.2,10132)
ATP-dependent phosphofructokinase Tb927.3.3270 (2.7, 35922)
Diacylglycerol kinase catalytic domain Tb927.8.5140 (2.2,16973)
sphingolipid delta 4 desaturase Tb927.6.3000 (2.3,10540)
fructose-1,6-bisphosphatase Tb09.211.0540 (2.3,13478)
glutathionylspermidine synthetase Tb11.12.0016 (2.1, 20983)
guanine deaminase Tb05.5K5.200+1 (2, 7271)
haloacid dehalogenase-like hydrolase Tb11.01.0120 (2.3, 8482)
hexokinase 1 Tb10.70.5820* (13.4, 27920)
hypothetical conserved, serine-esterase like motif Tb11.01.3580 (2.2, 10321)
iron/ascorbate oxidoreductase family protein Tb927.2.6180 (13.2, 6052), Tb927.2.6230 (6.9, 13271), Tb927.2.6310 (3.3, 8181)
lipase domain protein Tb927.3.3870 (3.1, 13228)
nucleoside phosphorylase Tb927.8.4430 (3.2, 23275)
phosphoglycerate kinase, glycosomal Tb927.1.700* (10.1, 32849)
pyruvate kinase 1 Tb10.61.2680* (3.5, 35164)
sphingomyelin synthase family Tb09.211.1020 (3.1, 9771), Tb09.211.1010 (2.3,)12554
Protein or lipid phosphorylation
casein kinase I, CK1 Tb10.70.5340 (2.6,12672)
cdc2-related protein kinase Tb11.47.0031 (3.1, 15760)
cyclin 3, mitotic cyclin Tb927.6.1460 (2.4, 11043)
dual specificity phosphatase Tb11.02.1640 (2.3, 5100)
protein kinase Tb927.5.3320 (2.4, 6629)
serine/threonine-protein kinase, NEK family Tb927.2.2120 (2.2, 11101), Tb927.4.5310 (2.6, 13985), Tb927.8.7110 (2, 16132)
TFIIF-stimulated CTD phosphatase Tb927.3.3380 (3, 8247), Tb10.61.2520 (2.5, 16649)
Protease-related
calpain cysteine peptidase Tb927.8.8330 (3.3, 19000)
cysteine peptidase C Tb927.6.560 (2, 17546)
Gp63 major surface protease homolog Tb11.02.5310 (2.3, 16249), Tb10.70.5290* (5.2,14867), Tb11.02.5630 (4.2, 10649), 
Tb11.02.5610 (3.7, 6645), Tb11.02.5640 (3.3, 12431), Tb11.0370 (3.6, 4695), Tb11.0380 (2.6, 
10329), Tb11.0360 (3.4, 9307)
hypothetical conserved, OTU protease domain Tb927.8.5050 (2.2, 13601)
hypothetical conserved, UIM domain Tb10.70.1130 (2.2, 20751)
inhibitor of cysteine peptidase chagasin family Tb927.8.6450 (2, 29643)
metacaspase Tb11.02.0730 (2.4, 11810), Tb927.6.930 (3, 1906), Tb10.70.5250 (15.1, 15483)
serine carboxypeptidase (CBP1) Tb10.70.7090 (3.9, 16383)
serine peptidase Tb927.3.4230 (2.7, 11496)BMC Genomics 2009, 10:482 http://www.biomedcentral.com/1471-2164/10/482
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slightly lower (1.6-1.8-fold), but high-confidence increase
in signal in slender BF. A few other genes showed similar
(1.5-1.9-fold) changes in expression, but had somewhat
lower confidence (q-value = 7.9). These included a CAMK
group protein kinase (Tb927.7.6580), a nucleoside phos-
phorylase (Tb927.8.4430), a tryparedoxin
(Tb927.3.5090) and two proteins with unknown function
that had higher signals in cBF, and a GRESAG4 that had a
higher signal in slender BF. These data contrast with a pre-
vious microarray study examining 550 genes that found
35 were upregulated in cBF and 3 were upregulated in
slender BF [12]. None of those 38 genes correspond to the
few genes that we identified above. Two sets of genes that
we identified as modestly upregulated were on the previ-
ous array, but these were not observed to be upregulated
in that analysis. The lack of consistency between the two
studies in this regard could arise from differences in the
strains or conditions (e.g., medium, serum, use of intact vs
immunocompromised animals). Nonetheless both stud-
signal peptidase type I Tb927.5.3220 (2.2, 13695)
Protein folding, modification and transport
acetyltransferase Tb927.1.4490 (2.7, 4473)
ADP-ribosylation factor Tb11.01.6060 (2.2, 4625)
chaperone protein DNAJ Tb927.4.3980 (3.4, 10760), Tb927.6.3120 (2.5, 17514)
dynamin vacuolar sortin protein 1 Tb927.3.4720 (2.3, 13449)
GPI inositol deacylase precursor Tb10.70.2420 (2.6, 21099)
heat shock protein HSP70-like protein Tb09.160.3090 (2.4, 26203)
HSR1-related GTP binding protein Tb927.4.2380 (2.0, 16054)
hypothetical conserved, TRAP alpha motif Tb927.7.2190 (2.1, 3176)
oligosaccharyl transferase subunit Tb927.5.890 (2.9, 10460)
protein disulfide isomerase, bloodstream-specific Tb10.6k15.2290 (2.4, 28599)
UDP-Gal/GlcNAc-dependent glycosyltransferase Tb927.3.5660 (2.0, 9638), Tb927.7.300 (2.1, 19406)
Surface or secreted, transporters
64 kDa invariant surface glycoprotein Tb927.5.1390 (5.5, 7559), Tb927.5.1430 (3.6, 6582), Tb927.5.1410* (17.1, 5352), 
Tb927.2.3270* (6.9, 18103), Tb927.2.3300* +3 (5.6, 13407), Tb927.2.332* (8.1, 14544), 
Tb11.47.0001* (3.3, 10214)
75 kDa invariant surface glycoprotein Tb927.5.350 (2.4, 13044), Tb927.5.360-Tb927.5.360b (4.7, 17510), Tb927.5.370 (6.2, 11233), 
Tb927.5.400 (4.2, 13688), Tb927.5.390* (5.9, 17712)
acidic phosphatase (ISG65-like) Tb927.5.630 (3.7, 29580)
flagellum-adhesion glycoprotein Tb927.8.4060 (4.5, 11088)
glycophosphatidylinositol phospholipase Tb927.2.600* (3.4, 17679)
haptoglobin-hemoglobin receptor Tb927.6.440 (4.0, 15595)
ABC transporter Tb11.02.3950 (2.1, 11483)
adenosine transporter Tb927.5.286b (2.3, 9396), Tb927.2.6200 (19.5, 2940), Tb927.2.6220 (20.7, 3409), 
Tb927.2.6320 (8.4, 10291), Tb927.2.6280 (20.1, 7137), Tb927.2.6240 (20.7, 7104)
amino acid transporter Tb927.4.4020 (2.7, 26379), Tb927.4.4860 (2.3, 9610)
aquaglyceroporin Tb10.61.2650 (4.2, 28913)
glucose transporter Tb10.6k15.2040 (2.7, 48061), Tb10.6k15.2030 (4.4, 23370)
glycerol uptake protein Tb10.61.0380 (2.3, 11746)
major facilitator superfamily protein Tb927.3.4070 (5.3, 24190), Tb927.3.4090 (5.1, 9918), Tb10.61.2750 (2.5, 8885)
UDP-galactose transporter Tb927.4.1640 (2.3, 5225)
Vacuolar-type Ca2+-ATPase 2 Tb927.8.1200 (2.5, 14542)
Other
kinesin Tb10.61.1750 (5.0, 24612), Tb927.6.4390 (2.4, 12826), Tb927.7.4110 (2.5, 4714)
nucleolar protein Tb09.160.1180 (2.3, 4877)
procyclin-associated gene Tb10.70.1310 (3.6, 9070), Tb10.70.1300 (9.9, 7362), Tb11.01.6210 (3.3, 22849), Tb11.01.6220 
(4.1, 10444)
retrotransposon hot spot protein Tb09.v4.0013 (7.2, 3458), Tb09.244.2180 (2.8, 1283)
sarcoplasmic reticulum glycoprotein Tb10.61.1710 (2.0, 9921)
VSG-related Tb927.1.5060 (2.5, 5925), Tb927.1.5170 (7.0, 8241), Tb927.2.2060 (3.1, 8575), Tb927.3.1470-
Tb927.3.1520 (4.3, 7116), Tb927.3.1500 (33.1, 13722), Tb927.3.1510 (12.5, 1450) 
Tb927.3.2540 (3.3, 2297), Tb927.3.5680 (6.1, 1903), Tb927.5.110 (4.1, 1468), Tb927.5.130 
(5.4, 5216), Tb927.8.7300+1 (3.7, 16812), Tb09.160.5350 (3.4, 9129), Tb09.v1.0300+1 (4.4, 
6354), Tb09.v1.0290+1 (4.2, 6386), Tb09.244.2330 (5.2, 3974), Tb09.244.2310 (7.6, 2584), 
Tb09.244.2280 (3.1, 881), Tb09.244.2240 (5.1, 2605), Tb09.244.2200 (4.3, 2404), 
Tb11.02.1566 (8.0, 12758)
aESAGs, GRESAGS, VSGs are not included. A complete list of the genes is found in Additional file 3.
bBold: gene was upregulated in all BF vs all PF conditions. Probe-sets detecting >1 gene indicated by "+", plus number of additional genes.
* marks known stage-regulated genes used in previous array study [12].
Table 3: Genes with functional annotation that are up-regulated in cBF as compared to PF-loga (Continued)BMC Genomics 2009, 10:482 http://www.biomedcentral.com/1471-2164/10/482
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Pairwise comparison of gene expression in different biological conditions Figure 4
Pairwise comparison of gene expression in different biological conditions. Nuclear genes with >2-fold change in 
expression between the two conditions indicated (by either Tukey medians or SAM-calculated mean) were categorized into 
different functional categories or locations. Categories with very few representatives in either stage are not shown. Genes 
annotated as hypothetical or hypothetical conserved were further categorized as encoding proteins having a signal sequence 
(hyp+sig) or having at least one internal potential membrane domain (hyp +TMD).
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ies do suggest that in vitro cultivation provides a reasona-
ble model for analysis of most mRNAs in slender BF.
A comparison of the rapidly dividing slender BF with the
non-dividing stumpy BF showed a total of 107 genes with
at least a 2-fold change in signal in the arrays, not includ-
ing VSGs. About twice as many genes were up-regulated in
slender forms (Table 4) as were up-regulated in stumpy
forms (Table 5). The most prominent categories of genes
showing increased signals in slender forms are those that
are related to the cytoskeleton, including the flagellum
(Figure 4B). Many of these genes are annotated as hypo-
thetical proteins, but they were detected in the flagellar
proteome [23]. Non-dividing forms do not build new
flagella or cytoskeleton. Additionally, several metabolic
enzymes were up-regulated, predominantly those which
are localized to the glycosome (a specialized peroxisome)
or are involved in glycolysis. Conversely, the entire set of
eight ESAG9 genes in the 927 strain were upregulated in
stumpy BF (from 2-fold to 30-fold), as were two genes
that are related to ESAG9. The function of ESAG9 is not
known; it was originally described as a gene found in a
VSG expression site (ES) in the closely related parasite
Trypanosoma equiperdum [24]. At that time, the authors
Table 4: Genes showing increased expression in slender BF as compared to stumpy BFa
description Genes (fold changea, slender signal)
adenylate kinase Tb927.2.5660 (2.09, 12440)
alanine aminotransferase Tb927.1.3950 (1.96, 10266)
amino acid transporter 8 Tb927.4.4860 (2.25, 11460)
cAMP-specific phosphodiesterase, PDEB1 Tb09.160.3590 (2.01, 6849)
clathrin heavy chain Tb927.3.930 (2.12, 10381), Tb10.70.0830 (2.1, 13711), Tb10.70.1720 (1.90, 4250)
ESAG8 H25N7.22 (2.16, 15567)
flagellar axoneme protein PF16 Tb927.1.2670 (1.91, 15581)
flagellar component PACRGA Tb927.3.2310 (1.74, 11680)
glycerol-3-phosphate dehydrogenase Tb11.02.5280 (2.19, 28619)
haptoglobin-hemoglobin receptor Tb927.6.440 (2.08, 14824)
histone H2A Tb927.7.6360 (2.31, 4541)
hypothetical Tb927.5.4010 (2.76, 18891), Tb05.5K5.220 (2.16, 8815), Tb927.8.7970 (2.65, 20178), 
Tb10.70.4020 (1.92, 7584), N19B2.190 (3.13, 7132)
hypothetical conserved Tb927.1.4310 (2.39, 16196), Tb927.3.1910 (1.92, 6794), Tb927.4.2740 (2.36, 20142), 
Tb927.4.4580 (2.28, 9393), Tb927.4.4690 (1.93, 16059), Tb927.4.4700 (2.08, 10495), 
Tb927.5.2950 (1.83, 12001), Tb927.6.3180 (1.88, 12401), Tb927.7.6910 (2.36, 11887), 
Tb927.8.1550 (2.26, 16363), Tb927.8.3820 (2.09, 4078), Tb927.8.6660 (1.76, 26059), 
Tb10.389.0720 (2.70, 14817), Tb10.61.2210 (2.95, 9224), Tb10.61.3130 (2.03, 15809), 
Tb10.6k15.0710 (1.84, 8318), Tb10.70.4030 (1.96, 13839), Tb10.70.5560 (2.26, 11345), 
Tb10.70.7280 (1.76, 12000), Tb11.01.2700 (2.40, 6975), Tb11.01.4030 (1.73, 21437), 
Tb11.01.6470 (2.52, 17105), Tb11.02.0810 (1.91, 5728), Tb11.02.1660 (2.32, 10253), 
Tb11.02.4380 (1.97, 14847), Tb11.02.4400 (1.76, 21856)
hypothetical conserved, EF hand Tb09.211.4820 (2.12, 6022)
hypothetical conserved, TPR repeats Tb11.03.0240 (1.89, 18392)
hypothetical conserved, WD40 repeat Tb09.211.4280 (1.99, 6137), Tb10.70.7320 (2.09, 12025), Tb11.02.5550 (2.01, 8496)
hypothetical conserved, zinc finger Tb10.389.0740 (2.97, 15526), Tb11.01.8270 (1.99, 19491)
hypoxanthine-guanine phosphoribosyltransferase Tb10.70.6660 (2.01, 12965)
inosine-adenosine-guanosine-nucleoside hydrolase Tb927.3.2960 (2.06, 16716)
64 kDa invariant surface glycoprotein Tb927.5.1410 (2.49, 8554), Tb927.5.1430 (2.02, 11573)
iron superoxide dismutase Tb11.01.7550 (2.26, 11504)
leucine-rich repeat protein Tb927.8.3790 (2.21, 6720)
mitochondrial carrier protein Tb927.5.1550 (2.00, 5469)
mitochondrial DNA ligase homolog Tb927.7.610 (1.96, 15064)
paraflagellar rod component Tb11.01.5100 (2.08, 19728)
paraflagellar rod protein Tb11.01.6740 (1.93, 17955)
phosphoglycerate kinase, glycosomal Tb927.1.700 (2.19, 35215)
protein kinase Tb11.01.4230 (2.55, 8847)
protein kinase, Aurora kinase AUK2 Tb927.3.3920 (1.97, 4982)
pumillio RNA binding protein PUF9 Tb927.1.2600 (2.39, 16018)
pyruvate kinase 1 Tb10.61.2680 (2.08, 29931)
RNA-binding protein Tb11.01.3940 (2.28, 5191)
serine/threonine protein phosphatase Tb05.5K5.30 (1.96, 5681)
SNF2 DNA repair protein Tb927.7.4650 (1.96, 8894)
a Fold-change as calculated by SAM analysis are shown; some genes showed 2-fold difference in Tukey means.BMC Genomics 2009, 10:482 http://www.biomedcentral.com/1471-2164/10/482
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noted that a related ESAG9 was transcribed independently
of the VSG ES. Seven of the eight annotated ESAG9 genes
encode proteins with a predicted signal sequence, but
none of these contain predicted transmembrane domains,
suggesting the ESAG9s could encode a family of secreted
proteins. The metabolic enzymes encoded by genes with
higher mRNA levels in stumpy BF were predominantly
mitochondrial, consistent with pre-adaptation for differ-
entiation into insect forms. We also noted the increased
mRNA for the PAD1 and PAD2 genes, which encode cit-
rate transporters and were previously shown to be upreg-
ulated in stumpy forms of T. brucei strain EATRO 2340
[25].
Comparison of gene expression of PF in different 
conditions
Unlike cBF, in vitro cultured PF can be grown to stationary
phase where they can persist for several days as viable cul-
tures. Thus, we could directly compare the abundance of
mRNAs in actively replicating (PF-log) and non-dividing
(PF-stat) cells. A total of 895 genes showed differential
expression (see Additional file 6), many more than the
107 genes differentially regulated between with the slen-
der (log) versus stumpy (stationary) BF. About three times
as many genes were up-regulated in PF-log as compared to
PF-stat. As shown in Figure 4C, this increase was reflected
across almost all categories of genes, except for proteins
categorized as unknown (both conserved and T. brucei-
specific). The most skewed group was genes annotated as
encoding hypothetical proteins (conserved or T. brucei-
specific) that have predicted transmembrane domains --
many more such genes were upregulated in stationary
phase than in log phase. For proteins with ascribed func-
tion, those associated with protein phosphorylation/
dephosphorylation were enriched in stationary phase. As
discussed above, some of changes in PF-stat may reflect
the decrease in cellular growth functions, or perhaps prep-
aration for development to epimastigotes. It is also possi-
ble that some transcripts with higher signals in PF-stat are
simply those that decay most slowly.
Genes encoded by the mitochondrial genome
Several genes on the mitochondrial maxicircle genome are
extensively remodeled by RNA editing to yield transcripts
encoding components of mitochondrial respiratory com-
plexes. Only 15 mitochondrial probe-sets could be
designed (see Additional file 7). Four corresponded to
both edited and unedited sequences, and six to never-
edited sequences, including the two rRNAs. Three corre-
sponded to edited sequences, two of which had corre-
sponding unedited probe-sets. From this limited set, a few
trends could be observed, which were compatible with
prior literature [26-28]. For example, 12S and 9S rRNA,
cytochrome b, cytochrome oxidase subunit I, and cyto-
Table 5: Genes showing increased expression in stumpy BF as compared to slender BF
description Genes (fold change, stumpy signal)
aquaporin 3 Tb927.6.1520 (1.67, 17418)
ESAG4 Tb11.03.0990 (2.65, 7195)
ESAG9 Tb927.1.5220 (4.68, 6148), Tb927.5.120 (3.86, 14115), Tb927.5.4620 (2.06, 3102), 
Tb927.7.170 (2.59, 24058), Tb09.160.5400 (6.63, 43669), Tb09.160.5430 (5.41, 6467), 
Tb09.v1.0330 (30,49, 25309), Tb11.1000 (4.20, 9262)
glutamate dehydrogenase Tb09.160.4310 (2.43, 12969)
GPEET2 procyclin Tb927.6.510 (8.51, 7966)
hypothetical conserved Tb927.2.2140 (3.16, 3032), Tb927.6.4270 (1.98, 6654), Tb927.7.4270 (2.49, 13877), 
Tb09.160.0465 (2.61, 14430), Tb09.211.1620 (1.90, 8475), Tb09.v1.0490 (2.18, 28015), 
Tb10.389.1860 (2.22, 6264)
hypothetical conserved, aminotransferase domain Tb927.4.2240 (2.16, 13035)
hypothetical conserved, ESAG9-like Tb09.142.0370 (7.52, 7916), Tb09.142.0380 (2.63, 18446)
hypothetical protein Tb09.v4.0151 (3.39, 27898), Tb10.70.2840 (2.57, 9259), Tb10.70.2850 (3.58, 3685)
major facilitator superfamily protein, PAD2 Tb927.7.5940 (2.04, 36576)
mitochondrial processing peptidase alpha subunit Tb11.02.1480 (2.01, 9711)
2-oxoglutarate dehydrogenase E2 component Tb11.01.3550 (2.29, 11013)
protein phosphatase with EF-Hand domains Tb927.8.1130 (2.24, 9691)
purine nucleoside transporter Tb09.160.5480 (2.34, 30007)
pyruvate dehydrogenase complex E3 binding protein Tb10.70.5380 (2.10, 13843)
RNA-binding protein RBP5 Tb11.01.3915 (2.85, 9818)
serine/threonine-protein kinase NrkA Tb927.8.6930 (1.78, 30611)
succinyl-coA:3-ketoacid coA transferase mitochondrial Tb11.02.0290 (1.86, 22800)
transketolase Tb927.8.6170 (2.16, 4917)
transporter Tb10.61.2747 (1.79, 9346)
VSG-related VR2.1 Tb11.01.4560 (2.48, 18586)
a Fold-change as calculated by SAM analysis is shown; some genes showed 2-fold difference in Tukey means.BMC Genomics 2009, 10:482 http://www.biomedcentral.com/1471-2164/10/482
Page 15 of 24
(page number not for citation purposes)
chrome oxidase subunit II (edited plus unedited) tran-
scripts all increased in stumpy BF and further increased in
PF-log, although some did not reach statistical signifi-
cance until PF-log phase. Somewhat surprisingly, ATP syn-
thase subunit 6 (edited), NADH dehydrogenase subunit
5, NADH dehydrogenase subunit 7 (edited) and NADH
dehydrogenase subunit 8 (edited) all showed increased
mRNA levels in stumpy BF, but decreased in PF-log. Unex-
pectedly, many of the signals reached their maximum in
PF-stat. This could reflect a potential differential stability
as compared to the nuclearly-encoded transcripts under
conditions of growth arrest, and would be highlighted by
the normalization procedure.
Gene families
We noted several tandem arrays of gene families contain-
ing non-identical genes that were differentially regulated.
Three families encoding proteins with multiple trans-
membrane domains are depicted in Figure 5. The first
cluster (Figure 5A) of genes are those in the recently
described PAD array of carboxylate transporters [25]. In
contrast to PAD1 and PAD2, which are induced in stumpy
BF [25], the other members of this gene family are either
constitutively expressed at the mRNA level or more highly
expressed in PF. PAD5 and PAD7 show an increase in
expression from stumpy forms to PF-log and even higher
expression in PF-stat. PAD8 showed similar expression in
all conditions except in PF-stat, which was ~1.5-fold
increased over PF-log (q-value = 4.89). Figure 5B shows an
unrelated gene family on chromosome 10 that also
encodes major facilitator proteins. These four genes show
a high level of conservation with one another, with long
stretches of amino acid identity. Two are most highly
expressed in BF, whereas the other two show a more com-
plex pattern of regulation. The final set of genes (Figure
5C) encodes a set of related proteins predicted to have
four to five transmembrane domains, four of these genes
are tandemly arrayed on chromosome 8. Here the mRNA
abundances of the three most closely related genes are
higher in the BF samples. In contrast, the first gene in the
array and another more divergent, unlinked gene on chro-
mosome 11 do not show this pattern, and have similar or
higher expression in PF.
VSGs and ESAGs
The T. brucei strain 927 genome contains approximately
1600 VSG genes (or pseudogenes), but each BF trypano-
some expresses only a single VSG, which covers the sur-
face of the parasite in a dense coat. Although T. brucei
possesses ~20 VSG ESs (located at telomeres of megabase-
and intermediate-sized chromosomes) [29], the expressed
VSG gene encoding the surface coat protein is located in
the sole active ES. In BF, transcription initiates in all ESs,
but attenuates rapidly in the inactive ESs, never reaching
the downstream genes including the resident VSG [30].
Figure 5
Differential expression of tandemly arrayed genes. A.
The PAD gene array of carboxylate transporter proteins
(PAD1, Tb9277.5930, PAD2, Tb927.7.5940, PAD3,
Tb927.7.5950, PAD4, Tb927.7.5960, PAD5, Tb927.7.5970,
PAD6, Tb927.7.5980, PAD7, Tb927.7.5990, PAD8,
Tb927.7.6000). Not shown is the unlinked PAD-like gene,
Tb927.8.1650, which is expressed constitutively to low lev-
els. B. A cluster of four genes encoding proteins of a major
facilitator family. C. A cluster of genes with five to six trans-
membrane domains. Four genes are tandemly linked on chro-
mosome 10 and the fifth, more divergent gene
(Tb11.39.0005) is on chromosome 11.
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Similarly, transcription of ESs initiates in PF, but tran-
script elongation is minimal [31]. A relatively small
number of apparently functional VSG genes exist on the
11 megabase-sized chromosomes in T. brucei. The mini-
chromosomes also contain a reservoir of apparently func-
tional VSG genes, but only a few have been sequenced. In
contrast, most VSG genes reside in sub-telomeric arrays
that are comprised of pseudogenes (which were not
included on these microarrays) and atypical VSG genes,
which encode proteins that are neither clearly pseudo-
genes nor clearly functional [11]. The pseudogenes pro-
vide the fuel for generating novel VSG genes by mosaic
gene conversion during antigenic variation, particularly
later in infection [32]. The VSG-related VR  genes are
located not in the telomeric ESs or sub-telomeric arrays,
but rather typically reside in chromosome-internal strand-
switch regions and lack the 70-bp repeats typically found
upstream of VSG genes [11,32]. The telomeric ESs and
sub-telomeric  VSG  arrays also contain hundreds of
ESAGs, many of which are pseudogenes. However, a
number of genes related to ESAGs (GRESAGs) have chro-
mosomal-internal location (the nomenclature discrimi-
nating ESAGs and GRESAGs was not consistently applied
as genes were named).
The microarray design used in this study, contained
probes for 74 VSGs, 70 atypical VSGs, and 46 VSGs that
were unclassified on VSGdb [33]; 21 sub-telomeric
ESAGs, 104 chromosome-internal ESAGs and GRESAGs,
as well as 17 ESAGs from three T. brucei strain 427 ESs (no
T. brucei strain 927 ESs have been annotated to date). This
VSG and ESAG subset of genes was represented by a total
of 357 probe-sets. Even though individual parasites
express only one ES (containing a single VSG and ~10
ESAGs) at a time, since the parasites have been main-
tained without regard for antigenic type, we expected that
there would be diverse set of VSG genes showing some
expression at the population level. In addition, we
expected that expression of these VSGs and ESAGs would
vary between biological replicates, and indeed, a subset of
VSG and ESAGs showed considerable variation in BF, but
not PF (Figure 6A), probably reflecting antigenic variation
within these populations. Thus, subsequent analyses were
carried out on the 15 individual samples rather than on
the mean of the biological conditions (see Additional file
8 for gene level data).
Hierarchical clustering of the 357 probe-sets (after log2-
transformation of the normalized expression values)
allowed us to define four distinct patterns of VSG gene
and ESAG expression (marked A-D in Figure 6B). Interest-
ingly, the distribution of VSG genes and ESAGs from dif-
ferent genomic locations within each group differed
markedly (see Figure 6B and 6C). Group A contained a
large number (137) of VSGs not expressed in any sample,
or only at low levels in some BF samples, exemplified by
gene 1 in Figure 6D. All these genes were located within
sub-telomeric clusters and were likely not transcribed at
any stages, except when translocated to the active expres-
sion site in small sub-populations of BFs. This group also
included five ESAGs from T. brucei 427 ESs that presuma-
bly either reside in inactive expression sites or are not
present in T. brucei 927.
A second group (B) contained 34 VSG  genes and 54
ESAGs, which were expressed at substantially higher (but
still relatively moderate) levels in BF and generally low
levels in PF. Many of these showed variable expression
levels in different biological replicates of the BF samples,
indicative of expression from active ESs in sub-popula-
tions of BF. This group contained VSG and VR genes from
sub-telomeric clusters (genes 2 and 3, in Figure 6D), as
well as from chromosomal-internal locations (mostly
VRs, e.g. gene 4). It also contained ESAGs and GRESAGs
from the 427 ES, sub-telomeric clusters and chromo-
somal-internal loci. Of particular interest are several
ESAG9 genes that are up-regulated only in stumpy BF (as
discussed above). While this group of genes has many of
the hallmarks of canonical VSG/ESAG  expression from
ESs, it should be noted that in many cases their signal lev-
els in PF were substantially above background; suggesting
that the genes are actively transcribed in PF, but the
mRNAs are less stable than in BF.
Unexpectedly, a group (C) of 34 sub-telomeric VSG and
nine  ESAG  genes showed variable expression levels in
both BF and PF. The function of these VSG  genes is
unclear, since they appear to encode both typical and
atypical VSGs. In particular, one group of four tandemly-
linked VSG genes from an allele-specific region of chro-
mosome 5 showed highest expression in PF-log cells (see
gene 5 in Figure 6D). Group C contains both sub-telom-
eric and internal genes encoding ESAGs 2, 3, 5, and 11.
Interestingly, several ESAG11-related genes and a VR are
located in a tandem array on chromosome 4, where they
are interspersed with genes encoding hypothetical pro-
teins. Since the hypothetical proteins show very similar
expression patterns to the adjacent ESAG11-related genes,
at least some may simply represent 3' UTRs of the neigh-
boring genes. Interestingly, this cluster is located between
rRNA and tRNA gene clusters, and would not be expected
to be transcribed, since it appears to lack the modified
chromatin found at typical RNA polymerase II transcrip-
tion initiation sites [15,16]. The signal levels for all these
genes is modest (<3000), and are lowest in stationary
phase, suggesting that they may merely represent
increased "background" transcription due their proximity
to the actively transcribed RNA genes. However, this does
not rule out functionality of this set of putative genes.BMC Genomics 2009, 10:482 http://www.biomedcentral.com/1471-2164/10/482
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The final group (D) of VSG  and  ESAG  genes were
expressed in all life cycle stages. All nine VSG/VR genes in
this group are located in chromosomal-internal loci: four
are annotated as VRs, four are atypical VSGs and one is
uncategorized. mRNA for several of the VR genes has pre-
viously been detected in PF using PCR [32]. One of the
VRs shows highest expression in PF-stat (gene 7 in Figure
6D). Three of the atypical VSG genes show similar expres-
Cluster analysis of ESAG and VSG gene expression Figure 6
Cluster analysis of ESAG and VSG gene expression. A. Signals from probes detecting VSG/VR genes. Density plot of gene-
level coefficient of variation for VSG genes, defined as the standard deviation across the three biological replicates divided by 
the mean value of the replicates. The lines are cBF (red), slender BF (orange), stumpy BF (yellow), PF-log (dark blue), and PF-
stationary (light blue). B. Heatmap of the ESAG/GRESAG and VSG/VR genes after hierarchical clustering of the individual sample 
log2-transformed raw expression values. The clusters were pooled into four different expression patterns as shown on left. At 
right the genomic location of genes is shown: 427-ES, those detected by probe-sets corresponding to sequenced 427 strain 
VSG expression sites; I, chromosome internal; ST, sub-telomeric as defined by occurring distal to the first or last strand-switch 
region on the chromosome. C. Representation of each gene class in the four clusters, classified as either sub-telomeric (VSG-
ST, ESAG-ST) or chromosome internal (ESAG-I, VSG-I). Some of the genes derived from the 427 ESs last are likely not present 
in strain 927, while the remainder reside in regions not sequenced in strain 927 such as the intermediate or minichromosomes 
and the telomeres. D. Examples of VSG/VR genes from the four groups. The mean and standard deviation of the individual sam-
ples in each biological condition is shown. Genes are: group A (1, VSG Tb11.57.0024), group B (2, VSG Tb09.v4.0012, 3, VR10 
Tb927.5.110, 4, VR16 Tb09.v1.0300), group C (5, unclassified VSG Tb05.5K5.440), and group D (6, atypical VSG Tb927.4.5400, 
7, VR Tb927.5.291b).
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sion in all stages (e.g., gene 6 in Figure 6D). These genes,
Tb927.4.5400, Tb927.4.5420 and Tb927.4.5430, along
with a 4th gene identical to Tb927.4.5420, are tandemly-
linked to form a small cluster just 5' (and on the opposite
strand) to the sub-telomeric VSG cluster at the "right" end
of chromosome 4. Interestingly, this cluster of genes is
immediately downstream of a convergent strand-switch
region that appears to contain an RNA polymerase tran-
scription initiation site in both BF and PF [16]. A large
number of ESAGs are also expressed in all life cycle stages;
of these most are chromosomal-internal GRESAG4 genes
that have been shown previously to be expressed in PF
[34]. However, two ESAG4s and an ESAG7 from the 427
ES show this expression pattern, as do six sub-telomeric
ESAGs (two encode ESAG3, two ESAG5, one ESAG4 and
one ESAG9-like). The functional significance of their
expression in PF is unknown.
Of the 215 VSG genes examined, 43 showed expression
levels above the bottom quartile (~4500) of all genes in at
least one BF sample. These included 10 classified as
encoding functional VSGs, and eight that were unclassi-
fied, but also included eight encoding atypical VSGs and
17 VRs. From these data it is apparent that at least some
atypical VSGs are expressed and hence likely to be func-
tional. Indeed a query on GeneDB for VSGs annotated as
being detected in proteomic analysis of BF [35] yielded
seven genes, two of which are atypical VSGs. Only nine of
the 43 VSG genes noted above were expressed below the
5th percentile (~1300) in PF. These included five encoding
typical VSGs (and two that were uncharacterized), but one
gene encoded an atypical VSG, and one VR gene also had
this expression pattern. Thus, these data suggest that the
functional diversity of VSG and VR genes is likely more
complex that currently appreciated.
Conclusion
The results obtained in our study for genes previously
shown to be differentially expressed in BF versus  PF,
including those used as controls in a previous microarray
analysis [12], allow us to critically assess the validity of
our analysis. As expected, mRNAs corresponding to pyru-
vate kinase 1, metacaspase 3, isoforms of ISG64, ISG65,
and ISG75, VSG glycophosphatidyl inositol phospholi-
pase, major surface protease MSP (also known as GP63)
isoforms A and C, hexokinase I and phosphoglycerate
kinase isoform C all showed increased levels in cBF; while
EP2 and EP-3-2 procyclins, a trans-sialidase, phosphoe-
nolpyruvate carboxykinase, cysteine-rich acidic integral
membrane protein (CRAM), a flagellar adhesion protein,
corset protein 17, and CAP5.5 [36] all showed increased
signal in PF-log samples, although the changes generally
were less dramatic than those seen on Northern blots and
in the previous microarray analyses. Seven genes previ-
ously used as differentially expressed controls in [12]
showed changes less than 2-fold in our hands. Four
showed more modest changes and one (encoding histone
H3) did not change between cBF and PF-log, although it
was down-regulated in PF-stat. Finally, recent data suggest
that two of those genes may not be regulated between
these stages [36,37]. Thus, there is good agreement
between the current results and previous work. Since eight
probes were used for most genes in our study, it is likely
that any changes we see are highly reliable. The somewhat
muted differences could be due to a lower sensitivity of
the microarrays or to strain variations [38].
The data we obtained shows that despite the lack of tran-
scriptional control for most genes, gene expression is
finely tuned during T. brucei development. While most of
changes in mRNA abundance were relatively modest,
some varied by 10- to 100-fold, and over one-fourth
changed at least 2-fold between the different conditions.
Many of these changes were easy to reconcile with known
changes in parasite biology: the transition from dividing
to non-dividing forms affects genetic functions such as
transcription and translation and the transition from
mammalian to insect stages affects metabolism, surface
proteins and transporters. A moderate number of genes
encoding proteins with functions associated with RNA
were differentially expressed, perhaps reflecting the
important role these play in post-transcriptional regula-
tion of gene expression. It is perhaps surprising that rela-
tively few genes encoding protein or lipid kinases and
phosphatases were highly regulated, although this may
reflect a predominant use of phosphorylation pathways to
modulate the activities of these enzymes themselves.
A recently published set of analyses of the transcriptomes
of the four developmental stages of Trypanosoma cruzi
indicated that up to 50% of genes show a statistically sig-
nificant difference in mRNA levels during parasite devel-
opment [39], a proportion considerably higher than that
which we observed in T. brucei. It is likely that as other
stages of the T. brucei life cycle are examined, the propor-
tion of genes determined to show significant regulation
during development will rise. Our findings can also be
compared to studies in related parasite Leishmania where
~3-10% of the genes showed changes of at least 2-fold
between rapidly-growing procyclic promastigotes, non-
dividing metacyclic promastigotes, and the more slowly-
growing amastigote forms [40-45]. While the studies in
Leishmania identified a heterogeneous, but overlapping,
set of mRNAs showing regulation in abundance, several
similarities with the present study emerge. These include
down-regulation of genes encoding translational machin-
ery (including tRNAs) in slower growing stages, as well as
substantial changes in mRNA levels for many metabolic
enzymes.BMC Genomics 2009, 10:482 http://www.biomedcentral.com/1471-2164/10/482
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Interestingly, our results show very little difference
between cultured and animal-derived T. brucei BF. Other
studies using stresses such as exposure to tunicamycin or
reducing agents, reduced serum or genetic manipulation
of specific genes showed few changes in RNA abundances,
suggesting that BF parasites have little ability to alter their
transcriptome following unexpected environmental
changes [12]. This contrasts with some reports of substan-
tial differences between axenic and animal-derived amas-
tigotes of Leishmania [46]. It remains to be seen whether
this difference is due to the extracellular nature of T. bru-
cei, methodological difficulties of extracting amastigotes
from macrophages, or novel environmental cues detected
by the Leishmania parasites.
Use of the Nimblegen arrays also allowed us to provide an
assessment of the relative abundance of transcripts within
a biological condition, over at least two orders of magni-
tude. While many of the highly expressed transcripts
encode well-characterized proteins, there still remain
many that have received little or no attention. The data
presented here provide an important foundation for
researchers interested in elucidating the unusual biology
of the parasite or developing new interventions to combat
the lethal disease they cause. It is now important to further
understand the mechanisms involving regulation of trans-
lation, protein activity, and protein turnover to realize the
full extent of developmental regulation in T. brucei. This is
underscored by recent work comparing changes in the
transcriptome and proteome during Leishmania differenti-
ation, which suggests that there is a relatively poor corre-
lation between the two and that translation and protein
stability play important roles in regulation of gene expres-
sion in trypanosomatids [47](Lahav et al., manuscript in
preparation). However, work in T. cruzi suggests a more
robust relationship [39], perhaps pointing to different
modes of gene regulation between the Leishmania  and
Trypanosoma genera.
Methods
Parasites and RNA preparation
The pleiomorphic T. brucei strain TREU927/4 was used for
all analyses. All procedures involving vertebrate animals
followed protocols approved by the institutional IACUC.
For isolation of slender BF and stumpy BF, Wistar rats
(retired-male breeders) were immunosuppressed with
750 rads. Animals were immediately infected with 1-2 ×
108 parasites by intraperitoneal injection and the para-
sitemia was monitored daily beginning on day 2 post-
infection. For slender BF populations, animals were sacri-
ficed for harvest on day 4, when the parasitemia was still
increasing. For stumpy BF populations, animals were sac-
rificed when the morphologically stumpy population in
the blood smear exceeded 70%. Blood from infected ani-
mals was harvested with 10 mg/ml heparin in phosphate-
buffered saline (PBS) with 10 mM glucose. The samples
were then centrifuged at 900 × g for 10 min and the buffy
coat containing the parasites extracted. To remove the
remaining red blood cells, the buffy coat was loaded onto
to a DE53 (Schleicher and Schuell) column that had been
equilibrated with room temperature PBS plus glucose,
hypoxanthine (0.35 g/ml) and L-cysteine (80 g/ml).
Parasites were eluted from the column with the same
buffer and pelleted at 900 × g for 10 min. RNA was imme-
diately isolated as described below.
Stumpy BF begin to transform to PF quickly and synchro-
nously, as determined by expression of EP procyclin on
their surface four hours after induction, while neither
slender or intermediate BF will express EP procyclin
within this time frame [5,48]. To assess EP procyclin
expression, ~5 × 107 purified parasites were pelleted and
resuspended in DTM medium [49] with 6 mM freshly pre-
pared cis-aconitate and incubated for 4 hours at 25°C.
Washed cells were fixed in PBS with 3.7% formaldehyde
for 10 min at room temperature. Fixed cells were washed
once with PBS and stored in 100 l PBS at 4°C for up to
24 hours. Cells were spotted on poly-L-lysine coated
slides and, after blocking with 10% goat serum, surface-
localized procyclin detected with monoclonal antibodies
with a mixture of two monoclonal antibodies against EP
procyclin (antibody 16, directed against the glutamine-
proline repeats of EP procyclin and antibody 418, also
directed against EP procyclin) [50] at a 1:500 dilution for
1 hour. Slides were processed and cells visualized as
described [51]. PF strain 29.13 and cBF single marker
strain were similarly stained as positive and negative con-
trols respectively. For all counts, at least one hundred cells
were scored.
HMI-9 medium [52] with 10% fetal bovine serum was
used for continuous culture of cBF. The three biological
replicates were prepared several months apart. Parasites
were seeded into 400 ml of media and grown to ~8 × 105
cells/ml, to obtain a log-phase population. Cells were pel-
leted and RNA isolated as described below.
Generation of PF from stumpy BF
Stumpy BF obtained from an infected rat by cardiac punc-
ture were diluted in SDM-79 medium [53] containing
15% fetal bovine serum. The sample was centrifuged at
200 × g for 10 min to pellet the majority of the blood cells,
while leaving the majority of parasites in the supernatant.
The supernatant was then transferred to a flask and cis-
aconitate was added to 6 mM to induce differentiation to
PF at 26°C. After 2 hours, most of the remaining blood
cells had settled to the bottom and the upper phase of the
medium was transferred to a fresh flask and allowed to
incubate overnight. The next day, the cells were again
transferred to a fresh flask and the cultures were moni-BMC Genomics 2009, 10:482 http://www.biomedcentral.com/1471-2164/10/482
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tored daily until parasites started growing. The growing PF
expressed EP procyclin in the immunostaining assay
described above. For PF-log samples, cultures were grown
to 4 × 106 cells/ml, split 1:1, and allowed to grow an addi-
tional 24 hours before harvest at densities of 6-7 × 106
cells/ml (see Additional File 1). For PF-stat samples, cul-
tures were started at 106 cells/ml and cell number and
integrity was monitored daily beginning day 3. RNA was
isolated on day 5, the first day without any increase in cell
density (at about 7.5 × 107 cells/ml). The next day cultures
showed a significant increase in the proportion of dead
cells.
Isolation of RNA
Cell pellets were resuspended in 1-2 ml TRIzol (Invitro-
gen), with a maximum of 5 × 108 cells per ml TRIzol. RNA
was then isolated according to the manufacturer's direc-
tions. The quality of the RNA was verified by running on
an Agilent 2100 Bioanalyzer. RNA was sent to Nimblegen
for cDNA synthesis using oligo-dT priming, labeling and
hybridization to oligonucleotide arrays. Because of the
method of priming, the expression levels of RNAs,
mRNAs and mitochondrially-encoded transcripts cannot
be directly compared. However, both edited and non-
edited mitochondrial transcripts of T. brucei have poly(A)
tails [54], although the tails are longer for edited tran-
scripts [55]. Because transcripts from genes that do not
encode proteins (e.g. snRNAs, tRNAs and snoRNAs) are
usually not polyadenylated, signals corresponding to
most of these genes were low, and probably resulted from
limited priming from oligoA tracts.
Array design
The nucleotide sequence of 8530 protein-coding
sequences (CDS) and 559 RNA genes predicted from the
T. brucei 927 genome assembly (version 4) was obtained
from the GeneDB ftp site (genes annotated as "hypotheti-
cal unlikely", pseudogenes, or residing on intermediate-
sized chromosomes were excluded) and provided to Nim-
blegen for array design, aiming for eight probes per CDS
and three probes per RNA (probes were 60 bp). Since the
strain 927 telomeres were not sequenced, we also
included 50 CDSs predicted from three BACs from strain
427 telomeric expression sites. In additional, the two RNA
genes and 18 CDSs from maxicircle (mitochondrial) DNA
[GenBank:M94286] and the corresponding edited tran-
scripts were included in the array design.
To identify probes that would likely hybridize with more
than one gene, we utilized CROSS_MATCH[56]. All probes to
the CDS and RNA dataset above, as well as the entire T.
brucei  927 genome sequence, were tested using a
min_match of 35 and min_score of 55. Gene-specific
probes were defined as those that had no more than one
high-quality match (i.e. 35 contiguous perfectly matched
nucleotides with no more than 5 mismatches per probe)
against the entire genome. All probes that were not spe-
cific to a single gene (or set of near-identical genes) were
removed from subsequent analyses. This resulted in 8004
probe-sets corresponding to nuclear protein-coding
genes, 106 corresponding to nuclear RNA genes, 14 corre-
sponding to maxicircle protein-coding genes and 2 corre-
sponding to maxicircle rRNA genes (see Additional file 2).
Of these, 345 probe-sets detected more than one identical
(or near-identical) protein-coding gene; a few of these
probe-sets detected a pseudogene or "hypothetical,
unlikely" gene in addition to the original gene of interest.
This was most common for VSGs. For simplicity, in this
communication we refer to all genes detected by a probe-
set as "a gene". In the final analyses, 93% of the CDS
probe-sets contained eight probes, while 54% of the RNA
genes were represented by three probes. Each 60 bp probe
was randomly assigned to three different spots on the
array.
Only 409 T. brucei genes could not be analyzed (see Addi-
tional file 9); these included mosaic genes, as well as those
for which probes could not be designed or for which all
probes matched other (mostly unannotated) regions of
the genome. Most corresponded to RNA genes, leaving
only 124 protein-coding genes without a corresponding
probe-set.
Analysis of microarray data
The probe intensity signals from the 15 microarray chips
(three biological replicates by five conditions), as pro-
vided by Nimblegen, were subjected to quantile normali-
zation to account for non-biological signal intensity
variation across the chips [57]. This data has been depos-
ited with the Gene Expression Omnibus (GEO) database
(Accession no.: GSE18049), and has also been provided
to TriTrypDB http://www.tritrypdb.org for public access.
A single gene-level value for each biological replicate was
determined by calculating a weighted mean of all probes
in each probe-set using the Tukey biweight formula,
which minimizes the influence of outlier values. The sta-
tistical significance of signal changes between samples
was assessed by either pair-wise or multiclass tests from
the Significance Analysis of Microarrays (SAM) software
package [58], as appropriate, using all three biological
replicates for each condition. We set the q-value to 5,
yielding a false discovery rate of 5% for the set of genes
identified. There was good agreement between genes
showing a 2-fold or greater change assessed by the SAM-
calculated mean and those identified using a Tukey
biweight mean of the biological replicates. Pair-wise anal-
yses considered both values, accepting all genes with at
least a 2-fold change by one method and at least a 1.7-fold
change by the other method.BMC Genomics 2009, 10:482 http://www.biomedcentral.com/1471-2164/10/482
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Several different cluster analyses were performed using the
MeV component of the TM4 software package [59]. The
three biological replicates were combined by Tukey
biweight function to give a single gene-level value for each
of the five conditions and hierarchical clustering [60] was
carried out on all 8110 probe-sets using the following
parameters: Gene Tree selection only; Gene Leaf Order
optimization; Euclidean Distance metric and complete
linkage clustering. In order to focus on genes showing the
most variation between biological conditions, we selected
those in which at least one condition showed >2-fold
deviation from the mean of all five biological conditions
and q-value of < 5% in multi-class SAM analysis, and
excluded all VSG and VSG-related (VR) genes and ESAG/
GRESAGs. The log2-transformed fold-values from the
resultant 534 probe-sets were K-median clustered [61] by
genes only using the Euclidian distance and 50 iterations,
with hierarchical clustering of genes within the nine clus-
ters using the parameters described above. The 357 probe-
sets representing VSG/VR genes and ESAG/GRESAGs were
separately analyzed by hierarchical clustering of values
(log2-transformed Tukey biweight means) for the individ-
ual biological samples for all five different conditions,
using the same parameters as above. The HCL tree was
split into six clusters and two of these clusters further
divided two sub-clusters. The clusters and sub-clusters
were then combined into four different groups based on
similarities in expression pattern.
All protein-coding genes were manually assigned (based
on their GeneDB product description and literature
review) into 17 functional categories that are particularly
relevant to trypanosomatid parasite biology. These
included:
- DNA-associated (histone-related or histone modifying,
proteins involved in DNA replication, repair, or chroma-
tin remodeling, proteins with DNA binding motifs, and
nucleases)
- ESAGs/GRESAGs
- Interacting (proteins with interaction motifs such as zinc
fingers, leucine rich repeats, PX domains, PH domains,
and WD40 domains but with no other attributed func-
tion)
- Metabolism (metabolic enzymes)
- Oxidative stress (peroxidases, peroxiredoxins, superox-
ide dismutases, trypanothione metabolism)
- Phosphorylation (protein and lipid kinases and phos-
phatases)
- Protease-related (peptidases, proteases, protease-related,
and ubiquitin pathway)
- Protein folding (chaperones, proteins involved in pro-
tein folding or unfolding)
- Protein transport/modification (proteins mediating pro-
tein trafficking within the cell including the endomem-
brane system and organelles or involved in modification
of proteins within the endomembrane system such as gly-
cosylation)
- RNA-associated (RNA binding proteins, helicases, nucle-
ases)
- Transcription (RNA polymerase subunits and transcrip-
tion factors)
- Translation (proteins involved in ribosome biogenesis or
translation including nucleolar proteins, ribosomal pro-
teins, tRNA synthetases and tRNA modifying enzymes)
- Transporter (membrane proteins transporting small
molecules)
- VSG/VR
- Other (any protein with functional annotation other
than those above, plus those with known subcellular loca-
tion discussed below)
- Unknown, conserved (those annotated in GeneDB as
"hypothetical protein, conserved and not assigned to any
of the categories above)
- Unknown, T. brucei-specific (those annotated in GeneDB
as "hypothetical protein" and not assigned to any of the
categories above)
A subset of proteins (~900) were assigned to subcellular
location categories on the basis of GeneDB annotation,
literature surveys, or proteomic analyses. Assignment to
the cytoskeleton included those identified in the flagellar
proteome [13], while those with mitochondrial location
included those identified in the high-confidence mito-
chondrial proteome [14]. Other assignments were less
exhaustive and focused on differentially expressed genes.
Surface/secreted proteins included those known to be
secreted or localized to the parasite surface based on
experimental analysis (ESAGs, GRESAGs, transporters,
and VSGs were not included). Both functional categories
and location were used to group genes for different analy-
ses, as indicated in the Figure Legends. Additional file 2
provides gene-level information on gene categories, clus-BMC Genomics 2009, 10:482 http://www.biomedcentral.com/1471-2164/10/482
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ters, probes and signals, and SAM analyses for all nuclear
genes studied.
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